Causes of Death among AIDS Patients after Introduction of Free Combination Antiretroviral Therapy (cART) in Three Chinese Provinces, 2010–2011 | PLOS ONE
![Gastrointestinal Disorders | Free Full-Text | Gastrointestinal Involvement in Primary Antibody Deficiencies Gastrointestinal Disorders | Free Full-Text | Gastrointestinal Involvement in Primary Antibody Deficiencies](https://www.mdpi.com/gastrointestdisord/gastrointestdisord-05-00006/article_deploy/html/images/gastrointestdisord-05-00006-g001.png)
Gastrointestinal Disorders | Free Full-Text | Gastrointestinal Involvement in Primary Antibody Deficiencies
![Effectiveness and safety of statins on outcomes in patients with HIV infection: a systematic review and meta-analysis | Scientific Reports Effectiveness and safety of statins on outcomes in patients with HIV infection: a systematic review and meta-analysis | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-022-23102-2/MediaObjects/41598_2022_23102_Fig4b_HTML.png)
Effectiveness and safety of statins on outcomes in patients with HIV infection: a systematic review and meta-analysis | Scientific Reports
![Cells | Free Full-Text | Hierarchical Clustering and Trajectory Analyses Reveal Viremia-Independent B-Cell Perturbations in HIV-2 Infection Cells | Free Full-Text | Hierarchical Clustering and Trajectory Analyses Reveal Viremia-Independent B-Cell Perturbations in HIV-2 Infection](https://www.mdpi.com/cells/cells-11-03142/article_deploy/html/images/cells-11-03142-g001.png)
Cells | Free Full-Text | Hierarchical Clustering and Trajectory Analyses Reveal Viremia-Independent B-Cell Perturbations in HIV-2 Infection
The Role of Klebsiella pneumoniae in Lung Abscesses: A Geographic Phenomenon (For Now!) [with Reply]
![EFFECTIVENESS AND TOLERABILITY OF DTG+3TC IN CLINICAL PRACTICE: EVIDENCE IN PLHIV FROM REAL-WORLD DATA EFFECTIVENESS AND TOLERABILITY OF DTG+3TC IN CLINICAL PRACTICE: EVIDENCE IN PLHIV FROM REAL-WORLD DATA](https://www.natap.org/2021/images/100221/100221-3/1002213.gif)
EFFECTIVENESS AND TOLERABILITY OF DTG+3TC IN CLINICAL PRACTICE: EVIDENCE IN PLHIV FROM REAL-WORLD DATA
Efficacy and tolerability of a fosamprenavir-ritonavir-based versus a lopinavir-ritonavir-based antiretroviral treatment in 82 t
![Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment- naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial - The Lancet Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment- naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial - The Lancet](https://www.thelancet.com/cms/attachment/2001012426/2003805168/gr1.gif)
Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment- naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial - The Lancet
![Biomedicines | Free Full-Text | Immunomodulatory Properties of Human Breast Milk: MicroRNA Contents and Potential Epigenetic Effects Biomedicines | Free Full-Text | Immunomodulatory Properties of Human Breast Milk: MicroRNA Contents and Potential Epigenetic Effects](https://pub.mdpi-res.com/biomedicines/biomedicines-10-01219/article_deploy/html/images/biomedicines-10-01219-g006.png?1653551977)
Biomedicines | Free Full-Text | Immunomodulatory Properties of Human Breast Milk: MicroRNA Contents and Potential Epigenetic Effects
![Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial - The Lancet Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial - The Lancet](https://www.thelancet.com/cms/attachment/2001012425/2003805153/gr1.gif)
Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial - The Lancet
![Characteristics of antiretroviral therapy-naïve HIV-1-infected patients... | Download Scientific Diagram Characteristics of antiretroviral therapy-naïve HIV-1-infected patients... | Download Scientific Diagram](https://www.researchgate.net/publication/335734373/figure/tbl1/AS:873042611822594@1585160987530/Characteristics-of-antiretroviral-therapy-naive-HIV-1-infected-patients-included-in-the.png)
Characteristics of antiretroviral therapy-naïve HIV-1-infected patients... | Download Scientific Diagram
![Polycationic HA/CpG Nanoparticles Induce Cross-Protective Influenza Immunity in Mice | ACS Applied Materials & Interfaces Polycationic HA/CpG Nanoparticles Induce Cross-Protective Influenza Immunity in Mice | ACS Applied Materials & Interfaces](https://pubs.acs.org/cms/10.1021/acsami.1c19192/asset/images/large/am1c19192_0005.jpeg)